Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1469825

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1469825

Global Viral Clearance Service Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

PUBLISHED:
PAGES: 178 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3920
PDF (10-user License)
USD 5450
PDF (Corporate User License)
USD 8600

Add to Cart

The global demand for Viral Clearance Service Market is presumed to reach the market size of nearly USD 3030.49 Million by 2032 from USD 858.09 Million in 2023 with a CAGR of 15.05% under the study period 2024 - 2032.

Viral clearance service refers to a process conducted by biopharmaceutical companies to ensure the safety of biological products by removing or inactivating viruses and other potential contaminants. This service involves rigorous testing and validation procedures to demonstrate the effectiveness of viral clearance methods such as chromatography, filtration, and inactivation techniques. Viral clearance services are critical in developing and manufacturing biologics, vaccines, and gene therapy products to mitigate the risk of viral transmission to patients.

MARKET DYNAMICS

The increasing prevalence of viral infections, outbreaks, and emerging pathogens, coupled with the growing need for biopharmaceutical products, including monoclonal antibodies, monoclonaland recombinant proteins, has heightened the need for robust viral clearance validation research to guarantee the safety and efficacy of biopharmaceutical products for human use. Viral clearance services play a critical role in assessing the viral safety of biologics by evaluating the effectiveness of viral inactivation and removal steps during manufacturing processes, driving their adoption across the biopharmaceutical industry. Additionally, stringent regulatory requirements and guidelines issued by health authorities such as the EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration) mandate the implementation of viral clearance studies as part of the regulatory approval process for biopharmaceutical products, driving market demand. Moreover, increasing complexity and diversity in biopharmaceutical production processes, including cell culture, fermentation, and purification, have created challenges in effectively addressing viral contamination risks, driving the need for specialized expertise and testing services offered by viral clearance service providers, further fuelling market growth.

Furthermore, the growing trend towards outsourcing viral clearance testing and validation studies by biopharmaceutical companies, driven by resource constraints, time-to-market pressures, and the need for independent third-party validation, has created opportunities for contract research organizations (CROs) and testing laboratories to offer comprehensive viral clearance services, driving market expansion. The evolving landscape of viral safety regulations, advancements in analytical techniques, and emerging trends in bioprocessing technology are expected to drive further innovation and investment in the market, supporting the development and commercialization of safe and effective biopharmaceutical products for global healthcare markets. However, evolving regulatory requirements, technological advancements, and competition from in-house viral clearance capabilities may challenge the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of viral clearance service. The growth and trends of viral clearance service industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the viral clearance service market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

  • Viral Removal
  • Viral Inactivation (Chemical, Radiation, Others)

By Application

  • Recombinant Proteins
  • Tissue And Blood-Derived Products
  • Vaccines
  • Others

By End-User

  • Biopharmaceuticals
  • Contract Research Organizations
  • Academic Research Institutes
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Viral Clearance Service market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Viral Clearance Service market include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA, WuXi AppTec, Clean Cells, Vironova Biosafety AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114131

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . VIRAL CLEARANCE SERVICE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Method
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY METHOD

  • 5.1 Overview by Method
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Method
  • 5.4 Viral Removal Historic and Forecast Sales by Regions
  • 5.5 Viral Inactivation (Chemical, Radiation, Others) Historic and Forecast Sales by Regions

6 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Recombinant Proteins Historic and Forecast Sales by Regions
  • 6.5 Tissue and Blood-derived Products Historic and Forecast Sales by Regions
  • 6.6 Vaccines Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-user
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-user
  • 7.4 Biopharmaceuticals Historic and Forecast Sales by Regions
  • 7.5 Contract Research Organizations Historic and Forecast Sales by Regions
  • 7.6 Academic Research Institutes Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE VIRAL CLEARANCE SERVICE COMPANIES

  • 9.1. Viral Clearance Service Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF VIRAL CLEARANCE SERVICE INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Texcell
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Eurofins Scientific SE
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Charles River Laboratories International Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Merck KGaA
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. WuXi AppTec
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Clean Cells
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Vironova Biosafety AB
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

Product Code: VMR112114131

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Method (USD MN)
  • Viral Removal Market Sales by Geography (USD MN)
  • Viral Inactivation (Chemical, Radiation, Others) Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Recombinant Proteins Market Sales by Geography (USD MN)
  • Tissue and Blood-derived Products Market Sales by Geography (USD MN)
  • Vaccines Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Biopharmaceuticals Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Academic Research Institutes Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Viral Clearance Service Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Viral Clearance Service Report
  • Market Research Process
  • Market Research Methodology
  • Global Viral Clearance Service Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Method
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Method (USD MN)
  • Viral Removal Market Sales by Geography (USD MN)
  • Viral Inactivation (Chemical, Radiation, Others) Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Recombinant Proteins Market Sales by Geography (USD MN)
  • Tissue and Blood-derived Products Market Sales by Geography (USD MN)
  • Vaccines Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Biopharmaceuticals Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Academic Research Institutes Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!